Heart failure is a life‐threatening disease and addressing it should be considered a global
health priority. At present, approximately 26 million people worldwide are living with heart …

The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

The European Society of Cardiology (ESC) has published a series of guidelines on heart
failure (HF) over the last 25 years, most recently in 2016. Given the amount of new information …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator) (Netherlands), P.
Christian Schulze (CPG Review Coordinator) (Germany), Magdy Abdelhamid (Egypt), Victor …

Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection
of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient’s interest …

Heart failure is a serious condition and equivalent to malignant disease in terms of symptom
burden and mortality. At this moment only a comparatively small number of heart failure …

Aims To test the effect of education and support by a nurse on self-care and resource utilization
in patients with heart failure. Methods A total of 179 patients (mean age 73, 58% male, …

The 2013 ESH/ESC guidelines continue to adhere to some fundamental principles that
inspired the 2003 and 2007 guidelines, namely (i) to base recommendations on properly …